Fig. 1.
Fig. 1. Patients with an undeleted GST genotype responded significantly better to induction therapy. / Thirty-six (81.8%) of 44 patients with undeleted genotype and 31 (60.8%) of 51 of those with GSTM1 or GSTT1deletions (or both deletions) achieved CR (P = .04). Early deaths (n = 11) were excluded from this analysis. Asterisk indicates statistically significant.

Patients with an undeleted GST genotype responded significantly better to induction therapy.

Thirty-six (81.8%) of 44 patients with undeleted genotype and 31 (60.8%) of 51 of those with GSTM1 or GSTT1deletions (or both deletions) achieved CR (P = .04). Early deaths (n = 11) were excluded from this analysis. Asterisk indicates statistically significant.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal